These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 14561184)
1. TNFalpha as therapeutic target: new drugs, more applications. Reimold AM Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):377-92. PubMed ID: 14561184 [TBL] [Abstract][Full Text] [Related]
2. Biological and clinical effects of anti-TNFalpha treatment. Valesini G; Iannuccelli C; Marocchi E; Pascoli L; Scalzi V; Di Franco M Autoimmun Rev; 2007 Nov; 7(1):35-41. PubMed ID: 17967723 [TBL] [Abstract][Full Text] [Related]
3. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases]. Lapadula G Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352 [TBL] [Abstract][Full Text] [Related]
4. New indications for treatment of chronic inflammation by TNF-alpha blockade. Reimold AM Am J Med Sci; 2003 Feb; 325(2):75-92. PubMed ID: 12589232 [TBL] [Abstract][Full Text] [Related]
5. [Approved indications and other possible utilizations of anti-TNFα biologic drugs]. Grassi W; Montecucco C Reumatismo; 2005; 57(4 Suppl):30-3. PubMed ID: 16385353 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitors of TNFalpha]. Brousse C Rev Med Interne; 2003 Feb; 24(2):123-6. PubMed ID: 12650894 [TBL] [Abstract][Full Text] [Related]
7. TNFalpha blockade in human diseases: mechanisms and future directions. Wong M; Ziring D; Korin Y; Desai S; Kim S; Lin J; Gjertson D; Braun J; Reed E; Singh RR Clin Immunol; 2008 Feb; 126(2):121-36. PubMed ID: 17916444 [TBL] [Abstract][Full Text] [Related]
9. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. Tobin AM; Kirby B BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217 [TBL] [Abstract][Full Text] [Related]
10. TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Wiedmann MW; Mössner J; Baerwald C; Pierer M Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):295-314. PubMed ID: 19594416 [TBL] [Abstract][Full Text] [Related]
11. TNFalpha blockade in human diseases: an overview of efficacy and safety. Lin J; Ziring D; Desai S; Kim S; Wong M; Korin Y; Braun J; Reed E; Gjertson D; Singh RR Clin Immunol; 2008 Jan; 126(1):13-30. PubMed ID: 17916445 [TBL] [Abstract][Full Text] [Related]
12. Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy. Suh YS; Kwok SK; Ju JH; Park KS; Park SH; Yoon CH J Korean Med Sci; 2014 Jan; 29(1):38-42. PubMed ID: 24431903 [TBL] [Abstract][Full Text] [Related]
13. Anti-TNF therapy for other inflammatory conditions. Tutuncu Z; Morgan GJ; Kavanaugh A Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S146-51. PubMed ID: 12463467 [TBL] [Abstract][Full Text] [Related]
14. [Should we be afraid of the anti-TNFalpha drugs in 2008?]. Gaudin P Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291 [No Abstract] [Full Text] [Related]
15. Differentiating the efficacy of tumor necrosis factor inhibitors. Haraoui B J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457 [TBL] [Abstract][Full Text] [Related]
16. [Spondylarthropathies and anti-TNFalpha drugs]. Pavy S; Allanore Y; Kahan A Rev Med Interne; 2005 Sep; 26(9):717-24. PubMed ID: 16154026 [TBL] [Abstract][Full Text] [Related]